Physician profile
Devon Consul
NPI 1710418876
$31,599.95
in general payments reported to CMS, 2019-2025
28 companies · $2,891 in 2025
The $2,891 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $103 · 2021: $1,461 · 2022: $868 · 2023: $17K · 2024: $9,150 · 2025: $2,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $8,875 · Travel and Lodging: $3,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,562.50 |
| Food and Beverage | $8,874.96 |
| Travel and Lodging | $3,731.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Life Sciences | $15,065.18 | 2023 | Flexband |
| Vilex LLC | $7,819.93 | 2023-2024 | |
| Extremity Medical | $4,516.78 | 2024-2025 | |
| Ossio INC | $1,000.00 | 2021 | |
| Stryker Corporation | $707.41 | 2021-2025 | Easyfuse, Inbone, Infinity |
| Averitas Pharma INC. | $378.45 | 2023-2025 | Qutenza |
| Kerecis Limited | $251.92 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Djo, LLC | $213.19 | 2021-2024 | Cmf |
| In2bones USA, LLC | $181.22 | 2021 | |
| Grt US Holding, INC. | $166.58 | 2022 | |
| Smith+Nephew, INC. | $149.01 | 2020-2025 | Stravix, Oasis, Grafix |
| Treace Medical Concepts, INC. | $143.37 | 2024-2025 | |
| Sanara Medtech INC. | $138.62 | 2024 | Celleraterx |
| Abbvie INC. | $138.32 | 2022-2024 | Dalvance |
| Depuy Synthes Sales INC. | $137.86 | 2022-2025 | Motoband |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $121.40 | 2023 | Tapestry |
| Polynovo North America LLC | $76.16 | 2023-2024 | Novosorb Btm |
| Kowa Pharmaceuticals America, INC. | $67.74 | 2022-2023 | Seglentis |
| Innovation Technologies INC | $59.70 | 2023-2024 | Irrisept |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.84 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $54.01 | 2022-2023 | Nuzyra |
| Bioventus LLC | $37.39 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Stimwave Technologies Incorporated | $22.27 | 2022 | |
| Midsouth Orthopedics INC. | $21.67 | 2024 | |
| Nabriva Therapeutics, Plc | $21.58 | 2022 | |
| Medtronic, INC. | $21.03 | 2023 | Intellis Adaptivestim |
| Bone Support INC. | $17.60 | 2024 | Ceramentbone Void Filler, Cerament G |
| Vertex Pharmaceuticals Incorporated | $15.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Consul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.